Artificial intelligence can cut costs while maintaining accuracy in colorectal cancer genotyping

AJ Kacew, GW Strohbehn, L Saulsberry… - Frontiers in …, 2021 - frontiersin.org
Rising cancer care costs impose financial burdens on health systems. Applying artificial
intelligence to diagnostic algorithms may reduce testing costs and avoid wasteful therapy …

[HTML][HTML] Seizing the transformative opportunity of multi-cancer early detection

S Ezell - 2021 - itif.org
Blood-based multi-cancer early detection (MCED) technologies hold the promise to
revolutionize America's cancer-screening paradigm, dramatically expanding the range of …

Chemotherapy delivery in early-onset colorectal cancer is impacted by urban versus rural settings in Colorado

DW Sheneman, J Hu, S Das, A Leal, SL Davis… - Colorectal …, 2024 - Taylor & Francis
Aim: To assess early-onset colorectal cancer (EOCRC) trends in Colorado for differences in
presentation stage, therapy, survival, geography, and financial impact. Materials & methods …

Does National Colorectal Cancer Screening Program Represent Good Value for Money? Results from a Return-on-Investment Model in Vietnam

N Quynh Anh, NT Ha - Health Services Insights, 2021 - journals.sagepub.com
To provide important evidence for the resource allocation process in Vietnam, this research
was conducted to explore the return on investment (ROI) of the national colorectal cancer …

Free CRC screening in rural Texas yields positive ROI

G Orsak - PharmacoEconomics & Outcomes News, 2019 - Springer
The researchers examined the ROI of a CRC outreach programme that provided education
and free colonoscopies and/or faecal immunochemical testing during the fiscal years 2016 …